14Q32.3 IGH GENE REARRANGEMENT (ALL,NHL) / HEPARIN BLOOD

image not found

NABL Cap Accredited 
The 14q32.3 IGH Gene Rearrangement Test using heparinized blood at Metropolis Healthcare detects genetic rearrangements in the IGH gene, commonly associated with acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL). This test helps identify chromosomal abnormalities that influence disease prognosis and treatment planning. Detecting IGH rearrangements is important for accurate diagnosis and therapy decisions. The test provides insights into the patient’s risk profile and response to treatment. It supports personalized care and monitoring of hematologic malignancies.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 6,030.00

Sample Type: HEPARIN BLOOD

Fasting Not Required


Booking Procedure:
  1. Technician from Metropolis will be assigned for a free home sample collection after booking confirmation.
  2. Sample will be collected by our technician at your address at given slot.
  3. You will get a payment link in 2 hours. You can make the payment online or pay cash to the technician.
  4. Soft copy reports will be sent to your email address within 24 to 48 hours.

Frequently Asked Questions (FAQ's):

1. What is the 14q32.3 IGH Gene Rearrangement Test using heparinized blood?
This test detects rearrangements in the IGH gene on chromosome 14 (14q32.3) in patients with ALL or NHL using a heparin-treated blood sample for accurate analysis.

2. Why is this test important?
It helps assess disease progression, prognosis, and guides personalized treatment strategies in hematologic malignancies.

3. Who should undergo this test?
Patients diagnosed with or suspected of having ALL, NHL, or other blood cancers may be advised to take this test.

4. How is the test performed?
At Metropolis Healthcare, a heparinized blood sample is collected and analyzed using advanced cytogenetic and molecular techniques for precise detection.

5. What do the results indicate?
Detection of IGH gene rearrangements provides information about disease type, prognosis, and treatment response, while absence suggests other genetic variants.

6. Are there any risks associated with the test?
The test is safe, with minimal risk related to blood sample collection.

7. Why choose Metropolis Healthcare for this test?
Metropolis Healthcare provides accurate genetic testing with advanced technology and expert analysis, ensuring reliable results for effective management of ALL and NHL.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab